Confronto
Oxytocin vs. Sincalide
Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.
Identità
Categoria
Ricerca (altro)
Ricerca (altro)
N. CAS
50-56-6
25126-32-3
Peso molecolare
1007.19 g/mol
1143.29 g/mol
Emivita
0.05 h
nessun dato
Sequenza
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2Meccanismo d'azione
Oxytocin
Oxytocin is synthesised in the hypothalamus and released via the posterior pituitary. Peripherally it binds the oxytocin receptor, a G-protein-coupled receptor, and through the phospholipase-C cascade and calcium release triggers contraction of uterine smooth muscle and milk ejection — the pharmacological basis of the obstetric approval. Centrally, oxytocin acts as a neuromodulator and has been linked to social bonding, trust and modulation of stress and anxiety circuits. Its central effects in humans are mechanistically incompletely understood, particularly because it is unclear to what extent peripherally or intranasally administered oxytocin crosses the blood-brain barrier.
Sincalide
Sincalide activates CCK receptors, triggering gallbladder contraction and pancreatic enzyme secretion. This effect is used diagnostically to measure the gallbladder ejection fraction (e.g. in HIDA scintigraphy).
Base di evidenze
Evidenza più alta
RCT sull'uomo
Studio sull'uomo
Studi
4
0
di cui sull'uomo
4
0
Effetti registrati
3
1
Contraddizioni aperte
1
0
Eventi avversi documentati
0
1
Stato legale
Voci complete
Frequently asked questions
- What is the difference between Oxytocin and Sincalide?
- Oxytocin is classified as "Ricerca (altro)", while Sincalide is classified as "Ricerca (altro)". Oxytocin: Oxytocin is an endogenous nonapeptide hormone of the posterior pituitary. In synthetic form (Pitocin, Syntocinon) it has been approved for decades to induce and augment labour and to control postpartum uterine bleeding. Strictly separate from this is intranasal use to influence social behaviour, trust, anxiety or autism symptoms: this use is unapproved, purely experimental, and yields inconsistent and often negative results in controlled trials. Sincalide: Sincalide is the synthetic C-terminal octapeptide of the hormone cholecystokinin (CCK-8). As Kinevac it is FDA-approved to stimulate gallbladder contraction for diagnostic imaging. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
- Which peptide is better supported by science, Oxytocin or Sincalide?
- The highest available evidence level is "RCT sull'uomo" for Oxytocin and "Studio sull'uomo" for Sincalide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
- What is the legal status of Oxytocin and Sincalide in Germany and the United States?
- Germania: Oxytocin — Su prescrizione, Sincalide — Non chiaro. Stati Uniti: Oxytocin — Su prescrizione, Sincalide — Su prescrizione. These are factual summaries with source and review date on the individual pages.